Transcat (NASDAQ:TRNS) Sets New 1-Year High at $117.63

Transcat, Inc. (NASDAQ:TRNS) reached a new 52-week high during trading on Thursday . The company traded as high as $117.63 and last traded at $117.37, with a volume of 16240 shares changing hands. The stock had previously closed at $115.21.

Analyst Ratings Changes

Several brokerages have commented on TRNS. HC Wainwright reaffirmed a “buy” rating and issued a $124.00 target price on shares of Transcat in a research note on Tuesday, April 16th. Oppenheimer reissued an “outperform” rating and set a $125.00 price objective (up previously from $120.00) on shares of Transcat in a research report on Thursday, April 18th. Finally, TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a report on Wednesday, January 31st.

Transcat Price Performance

The stock has a market capitalization of $1.04 billion, a P/E ratio of 88.62 and a beta of 0.61. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01. The business’s 50 day simple moving average is $109.69 and its two-hundred day simple moving average is $103.62.

Insider Buying and Selling

In other news, Director Charles P. Hadeed sold 700 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $113.00, for a total value of $79,100.00. Following the completion of the sale, the director now owns 22,678 shares in the company, valued at approximately $2,562,614. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In related news, Director Charles P. Hadeed sold 700 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $113.00, for a total transaction of $79,100.00. Following the completion of the transaction, the director now owns 22,678 shares in the company, valued at $2,562,614. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Lee D. Rudow sold 2,373 shares of the business’s stock in a transaction dated Saturday, March 30th. The shares were sold at an average price of $111.43, for a total transaction of $264,423.39. Following the completion of the transaction, the chief executive officer now owns 103,688 shares in the company, valued at $11,553,953.84. The disclosure for this sale can be found here. 4.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TRNS. Russell Investments Group Ltd. increased its stake in shares of Transcat by 8.6% in the first quarter. Russell Investments Group Ltd. now owns 26,713 shares of the scientific and technical instruments company’s stock worth $2,977,000 after purchasing an additional 2,121 shares in the last quarter. Swiss National Bank boosted its position in shares of Transcat by 1.2% during the 1st quarter. Swiss National Bank now owns 17,415 shares of the scientific and technical instruments company’s stock valued at $1,941,000 after acquiring an additional 200 shares during the last quarter. Essex Investment Management Co. LLC raised its position in shares of Transcat by 1.5% during the 1st quarter. Essex Investment Management Co. LLC now owns 37,435 shares of the scientific and technical instruments company’s stock valued at $4,171,000 after buying an additional 569 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of Transcat by 24.2% during the 1st quarter. BNP Paribas Financial Markets now owns 14,024 shares of the scientific and technical instruments company’s stock valued at $1,563,000 after purchasing an additional 2,737 shares during the last quarter. Finally, Conestoga Capital Advisors LLC boosted its stake in Transcat by 0.6% in the first quarter. Conestoga Capital Advisors LLC now owns 767,206 shares of the scientific and technical instruments company’s stock worth $85,490,000 after buying an additional 4,345 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.